Skip to main content

Table 1 CVD polypills for use in the INTEGRATE study

From: An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trial

Tablet name

ACEI/ARB

Second antihypertensive agent

Statin

Antiplatelet agent

“Polypill Perindap Asp”

Perindopril erbumine (4 mg)

Indapamide (1.25 mg)

Rosuvastatin (10 mg)

Aspirin (100 mg)

“Polypill Perindap”

Perindopril erbumine (4 mg)

Indapamide (1.25 mg)

Rosuvastatin (10 mg)

“Polypill Hydrotelmi Asp”

Telmisartan (40 mg)

Hydrochlorothiazide (12.5 mg)

Rosuvastatin (10 mg)

Aspirin (100 mg)

“Polypill Hydrotelmi”

Telmisartan (40 mg)

Hydrochlorothiazide (12.5 mg)

Rosuvastatin (10 mg)

“Polypill Peramlo Asp”

Perindopril erbumine (4 mg)

Amlodipine (5 mg)

Rosuvastatin (10 mg)

Aspirin (100 mg)

“Polypill Peramlo”

Perindopril erbumine (4 mg)

Amlodipine (5 mg)

Rosuvastatin (10 mg)

“Polypill Amtelmi Asp”

Telmisartan (40 mg)

Amlodipine (5 mg)

Rosuvastatin (10 mg)

Aspirin (100 mg)

“Polypill Amtelmi”

Telmisartan (40 mg)

Amlodipine (5 mg)

Rosuvastatin (10 mg)

  1. ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker